Find investors
← Back to all investors
Todd Rainville
ResearchedAngel Investors

Todd Rainville

Partner, Business Development

Angel InvestorsSeed Round
Pitch Todd

Get their honest, personalized take on your startup.

Sign in to pitch Todd

At a glance

Full Name
Todd M. Rainville
Title
Co-Founder & Managing Partner, Great River Capital Partners (formerly Partner, Business Development, JMC Capital Partners)
Firm
Great River Capital Partners (GRCP)
Firm Type
Private equity (lower-middle-market / industrial buyouts); also an active angel investor and Steering Committee member of the Cherrystone Angel Group
Investment Stage
Buyout / growth equity at GRCP; seed-stage as an angel
Check Size
Not publicly disclosed
Target Company Profile
Mid-sized, often founder- or family-owned industrial technology and services companies; early-stage startups as a personal angel
Sector Focus
Industrial technology, manufacturing, and industrial services; medtech/diagnostics, robotics, agtech, and software via angel deals
Geographic Focus
United States (Northeast / New England emphasis)
Location
Boston, MA (firm); resides in Wayland, MA

Background

Todd Rainville is the co-founder and Managing Partner of Great River Capital Partners (GRCP), a Boston-based private equity firm he launched in 2020 with a narrow mandate: "acquiring mid-sized industrial technology and services companies. That is all we do." The firm partners with business owners to build long-term value through a combination of organic growth and strategic add-on acquisitions, drawing on what it describes as roughly 30 years of collective investing experience in the sector.

Before founding GRCP, Rainville was a Partner and member of the Investment Committee at JMC Capital Partners, which he joined in February 2017 to lead the firm's Business Development Team — identifying uniquely positioned industrial companies, building relationships with founders and owners, and structuring deals. His earlier career spans roughly 20 years of private equity and finance: he was a partner at Symmetric Capital, and spent nearly a decade combined across Summit Partners (where he began in the late 1990s) and Ampersand Capital Partners. His work has covered expansion financings, recapitalizations, and leveraged buyouts, concentrated in the industrial and technology sectors.

Rainville holds a Bachelor of Arts, magna cum laude, in Economics from Bates College and an MBA from Harvard Business School. Beyond his institutional PE work, he is an active angel investor and serves on the Steering Committee of the Cherrystone Angel Group, Rhode Island's first organized angel investment group (founded 2004, 60+ members). The "Angel Investors / Seed Round" classification reflects this personal early-stage investing rather than GRCP's buyout strategy.

Investment Thesis & Focus

  • Institutional (GRCP): Disciplined, single-thesis private equity — "a private equity investment firm with a narrow focus on acquiring mid-sized industrial technology and services companies." Value creation comes from organic growth plus complementary add-on acquisitions, in partnership with existing owners and management.
  • Deal types: Traditional expansion financings, recapitalizations, and leveraged buyouts — structures that let founders/owners take some chips off the table while staying involved.
  • Sector conviction: Deep specialization in industrial manufacturing, industrial technology, and services; this is where his track record and board experience are concentrated.
  • Angel investing: Personally backs early/seed-stage companies, spanning medical devices and diagnostics, robotics, agtech, electronics, and software — often New England–based and frequently sourced through angel networks (Cherrystone Angel Group; co-investments alongside groups like Boston Harbor Angels).
  • What makes him say yes: A strong founder/owner relationship and a credible path to long-term value creation; he is described as someone who cultivates founder relationships and structures creative deals rather than chasing pure financial engineering.

Notable Investments

  • Sybari Software — security software; acquired by Microsoft.
  • MediaQ — graphics/display chips; acquired by NVIDIA.
  • K-TEK — level-measurement instrumentation; acquired by ABB Group.
  • ChanTest — ion-channel drug-screening services; acquired by Charles River Laboratories.
  • Biomedical Structures — medical textiles; merged with Confluent Medical.
  • Source Code — rugged/embedded computing; backed by Cerberus Capital.
  • myBiometry — at-home asthma/COPD diagnostics (fenoTRACK); listed as an investor following its $5M oversubscribed seed round announced November 2024 (led by Dexcom Ventures).
  • Jaia Robotics — autonomous micro-AUV marine robotics.
  • Farmblox — farm monitoring/agtech.
  • Lenoss Medical — medical devices.
  • Torus, Alloy Hardfacing, Micro Precision Technologies, Conductive Containers — industrial machinery, electronics, and packaging.
  • Asearis, iQ3Connect — software / technical software.
  • Abstract Ice — real estate.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.